Rusi Pharma Pvt Ltd - Due diligence report

A 360° intelligence report on Rusi Pharma Pvt Ltd: trust score, financial health, credit view, compliance, directors, growth and distress si…

1992-10-16 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
RP Rusi Pharma Pvt Ltd
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Rusi Pharma Pvt Ltd — 360° Intelligence Report

Generated from MCA filings & public records
62/100
Trust Score
Moderate

Rusi Pharma Pvt Ltd is assessed as Moderate with a Trust Score of 62/100. Rusi Pharma Pvt Ltd is an active private limited indian non-government company incorporated in 1992, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Rusi Pharma Pvt Ltd snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
62/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
61/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
25/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 4 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 5 satisfied (6.01 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Bank Of Baroda1 48.0 cr
Central Bank Of India1 48.0 cr
The Saraswat Co-Op Bank Ltd3 48.0 cr
Compliance Score: 61/100 Moderate
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2020 - filings overdue.
  • Litigation present in 2 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (2)
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
MONIKA 01234567 Director 01/04/2018 6 yrs Approved
SUDHIR KUMAR 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • 2 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Rusi Remedies Private Limited Associate Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 60
Growth signals & trust indicators
Latest year revenue grew 38%.
Operating for 33+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Negative net worth.
Statutory filings appear overdue.
2 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence61/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment43/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view44/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
19 Dec 2023
Director ceased
SURESA CHANDA
Director ceased
LEKH RAJ
28 Jun 2021
Director appointed
MONIKA (Additional Director)
23 Mar 2021
Director ceased
MONIKA
03 Oct 2020
Last AGM held
Annual general meeting
31 Mar 2020
Latest balance sheet
Filed with ROC
25 Jan 2019
Director appointed
SUDHIR KUMAR (Additional Director)
22 Jan 2019
Director ceased
RAVI RAMJI JAISWAL
Director ceased
RAMJI RAMDAS JAISWAL
11 Jun 2018
Charge satisfied
Bank Of Baroda
09 May 2018
Director ceased
SAKSHAM GILHOTRA
30 Sep 2017
Director ceased
SUDHIR KUMAR
30 Jul 2017
Director ceased
NIDHI KARNWAL
Director ceased
LALIT KUMAR
03 Jul 2017
Director ceased
AMIT SHARMA
10

Key Observations

Auto-generated from the data above
Revenue declined 1.42 over the last 3 financial year(s).
Net profit margin moved from 2.1x to 24%.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
All 5 registered charge(s) stand satisfied - past borrowings repaid.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2017 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Omkarchemicals U24110MH1995PLC088969 Badlapur, Maharashtra, India
Shree Ishita Pharmaceuticals Private Limited U24231GJ1986PTC008596 Ahmedabad, Gujarat, India
Biotrack Technology Private Limited U24129TN2002PTC050112 Chennai, Tamil Nadu, India
Sos Organics Private Limited U63040DL2002PTC116902 New Delhi, Delhi, India
Rachamallu Carbons Private Limited U24100AP2012PTC082256 Tadipatri, Andhra Pradesh, India
Rajasthan Pesticides Limited U24219RJ1997PLC013384 Jaipur, Rajasthan, India
Kapila Chemicals Pvt Ltd U24129WB1989PTC047243 P O & Dist Hooghly, West Bengal, India
Stanchem Private Limited U24200MH1972PTC015756 Ambernath, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Rusi Pharma Pvt Ltd before audits and certifications: compliance score 61/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Rusi Pharma Pvt Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 50/100, margin trends, ownership structure and peer set for Rusi Pharma Pvt Ltd - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 62/100, distress signals and MSME payment-delay disclosures - know whether Rusi Pharma Pvt Ltd pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Rusi Pharma Pvt Ltd - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Rusi Pharma Pvt Ltd an active company?

Rusi Pharma Pvt Ltd has MCA status “Active” with a compliance score of 61/100 (Moderate).

Is Rusi Pharma Pvt Ltd financially healthy?

Rusi Pharma Pvt Ltd has a Financial Health Score of 25/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Rusi Pharma Pvt Ltd?

Its overall Trust Score is 62/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Rusi Pharma Pvt Ltd?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Rusi Pharma Pvt Ltd have loans or charges against its assets?

No open charges - all 5 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Rusi Pharma Pvt Ltd up to date with its ROC filings?

Last balance sheet is for Mar 2020 - filings overdue. Overall compliance score: 61/100 (Moderate).

Is it risky to lend to Rusi Pharma Pvt Ltd?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.